Early-onset epileptic encephalopathy and intellectual disability due to GRIN2A mutation

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:289266OMIM:245570E72.1
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Early-onset epileptic encephalopathy and intellectual disability due to GRIN2A mutation is a rare genetic brain disorder caused by changes (mutations) in the GRIN2A gene. This gene provides instructions for making a protein that is part of a receptor called NMDA, which plays a critical role in how brain cells communicate with each other, especially during learning and memory formation. When this gene is not working properly, it can lead to seizures that begin early in life, often in infancy or early childhood, along with significant delays in thinking, learning, and development. Children with this condition typically experience frequent and sometimes severe seizures that can be difficult to control with standard medications. The seizures themselves, combined with the underlying brain dysfunction, contribute to what doctors call "epileptic encephalopathy" — a situation where the seizure activity itself worsens brain function over time. Intellectual disability can range from mild to severe, and many children also have speech and language difficulties, which is a hallmark feature of GRIN2A-related disorders. There is currently no cure for this condition. Treatment focuses on controlling seizures with anti-seizure medications, though finding the right combination can be challenging. Speech therapy, occupational therapy, physical therapy, and special education services are important parts of the overall care plan. Research into targeted therapies that address the specific NMDA receptor dysfunction is ongoing and offers hope for more effective treatments in the future.

Key symptoms:

Seizures that start early in lifeIntellectual disabilitySpeech and language delaysDifficulty learning new skillsMovement problems or clumsinessBehavioral difficultiesAttention problemsMuscle tone abnormalities (too stiff or too floppy)Sleep disturbancesDifficulty with fine motor skills like writing or buttoning clothesSocial interaction challengesRegression or loss of previously learned skills during seizure episodesFeeding difficulties in infancy

Clinical phenotype terms (29)— hover any for plain English
EEG with multifocal slow activityHP:0010844Profound global developmental delayHP:0012736Diffuse cerebral atrophyHP:0002506
Inheritance

Variable

Can be inherited in different ways depending on the underlying gene

Age of Onset

Infantile

Begins in infancy, roughly 1 month to 2 years old

Orphanet ↗OMIM ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Early-onset epileptic encephalopathy and intellectual disability due to GRIN2A mutation.

View clinical trials →

No actively recruiting trials found for Early-onset epileptic encephalopathy and intellectual disability due to GRIN2A mutation at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Early-onset epileptic encephalopathy and intellectual disability due to GRIN2A mutation community →

No specialists are currently listed for Early-onset epileptic encephalopathy and intellectual disability due to GRIN2A mutation.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Early-onset epileptic encephalopathy and intellectual disability due to GRIN2A mutation.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Early-onset epileptic encephalopathy and intellectual disability due to GRIN2A mutationForum →

No community posts yet. Be the first to share your experience with Early-onset epileptic encephalopathy and intellectual disability due to GRIN2A mutation.

Start the conversation →

Latest news about Early-onset epileptic encephalopathy and intellectual disability due to GRIN2A mutation

No recent news articles for Early-onset epileptic encephalopathy and intellectual disability due to GRIN2A mutation.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Questions for your doctor

Bring these to your next appointment

  • Q1.What specific GRIN2A mutation does my child have, and what does it mean for their outlook?,Which anti-seizure medications are most likely to help, and what side effects should I watch for?,Are there any targeted or experimental therapies being studied for GRIN2A-related epilepsy?,How often should my child have EEGs and developmental assessments?,What therapies (speech, occupational, physical) should we start, and how often?,What should I do if my child has a prolonged seizure — do we need a rescue medication at home?,Should other family members be tested for the GRIN2A mutation, and what is the chance of this happening again in a future pregnancy?

Common questions about Early-onset epileptic encephalopathy and intellectual disability due to GRIN2A mutation

What is Early-onset epileptic encephalopathy and intellectual disability due to GRIN2A mutation?

Early-onset epileptic encephalopathy and intellectual disability due to GRIN2A mutation is a rare genetic brain disorder caused by changes (mutations) in the GRIN2A gene. This gene provides instructions for making a protein that is part of a receptor called NMDA, which plays a critical role in how brain cells communicate with each other, especially during learning and memory formation. When this gene is not working properly, it can lead to seizures that begin early in life, often in infancy or early childhood, along with significant delays in thinking, learning, and development. Children with

At what age does Early-onset epileptic encephalopathy and intellectual disability due to GRIN2A mutation typically begin?

Typical onset of Early-onset epileptic encephalopathy and intellectual disability due to GRIN2A mutation is infantile. Age of onset can vary across affected individuals.